The oncology drug market is huge -
> $200 billion per year .
The total cancer drug market though — is not as focused into the main drugs as we might think -( I’m out of my depth ,would have to go looking for stats) .
Facebook page , or a focused spotlight onto Bisantrene is not a silly idea - and again , at least has efficacy and Cause !
There is plenty of room in the oncology market , and can argue Need especially in Paediatric AML and other acute blood involved cancers , and compromised and highly refractory AML ( & other cancer) sufferers -for Bisantrene.
In terms of potentially many Lives saved - and very equitable costs to bring to market , can easily be justified imo . I’m off to work .
News or developments soon let’s hope
Responsibilities of the team, page-28
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
-0.015(0.96%) |
Mkt cap ! $267.5M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.62 | $1.53 | $200.7K | 127.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1375 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 3000 | 1 |
View Market Depth
| Last trade - 14.54pm 16/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |